Instagram Ern-EyeFacebook Ern-EyeTwitter Ern-EyeLinkedIn Ern-EyeYouTube Ern-EyeHow to use the speech recognition tool?
NCT01521793
RET IRD 02
Repeated Treatments of QLT091001 in Subjects With Leber Congenital Amaurosis or
Retinitis Pigmentosa (Extension of Study RET IRD 01)
Type: Interventional
Status of the trial: Completed
Orphan Drug Recognition: NA
Inclusion
- Opening Date: 2012-01-01
- Closing Date: 2014-05-01
Criteria
Children: Yes
Adults: Yes
Funder Type: private
HCP: Principal investigators
HCP: Other investigators
Within ERN-EYE members
Workgroups
Retinal Rare Eye Diseases (WG1)
This ERN is supported by:
